Cargando…
RA and ω-3 PUFA co-treatment activates autophagy in cancer cells
Retinoic acid (RA), is a promising therapeutic agent for the treatment of breast cancer. However, metabolic disorders and drug resistance reduce the efficacy of RA. In this study, we found that RA and ω-3 polyunsaturated fatty acids (ω-3 PUFAs) synergistically induced cell death in vitro and in vivo...
Autores principales: | Zhu, Shenglong, Lin, Guangxiao, Song, Ci, Wu, Yikuan, Feng, Ninghan, Chen, Wei, He, Zhao, Chen, Yong Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752509/ https://www.ncbi.nlm.nih.gov/pubmed/29312596 http://dx.doi.org/10.18632/oncotarget.22629 |
Ejemplares similares
-
ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell lines
por: Lin, Guangxiao, et al.
Publicado: (2017) -
ω-3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases 2014
por: Weylandt, Karsten H., et al.
Publicado: (2015) -
Cardioprotective Effects of ω-3 PUFAs in Chronic Kidney Disease
por: Lee, Su Mi, et al.
Publicado: (2013) -
A Low ω-6 to ω-3 PUFA Ratio (n–6:n–3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth
por: Van Name, Michelle A, et al.
Publicado: (2020) -
Relevance of ω-6 GLA Added to ω-3 PUFAs Supplements for ADHD: A Narrative Review
por: D’Helft, Jelle, et al.
Publicado: (2022)